Head-to-head dispatch
HealthSource vs TelePeptide
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.
Marked down on: No physician names or clinical leadership disclosed on public pages
Desk Score
TelePeptide is a LegitScript-certified US direct-pay telehealth practice offering physician-supervised compounded GLP-1 therapy — semaglutide and tirzepatide — in injectable and oral dissolvable tablet…
Marked down on: Compounded medications are not FDA-approved; no pharmacy partner named publicly
HealthSource takes this head-to-head with the higher Desk Score, 84/100 (B) against 67/100 (C) for TelePeptide. TelePeptide still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
HealthSource
84/100
B
TelePeptide
67/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | HealthSource | TelePeptide |
|---|---|---|
| Semaglutide | $199/mo (all doses, compounded) | $199/mo (starting dose, annual plan, compounded oral) |
| Tirzepatide | $299/mo (all doses, compounded) | $219/mo (starting dose, annual plan, compounded oral) |
| Coverage | All 50 states | Coverage not published |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | Readers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo. | Readers who want all-in compounded GLP-1 (sema/tirz, injectable + oral) from $169/mo; LegitScript-certified, 48 states. |
| Desk Score | 84/100B | 67/100C |
The verdict
Desk pick — HealthSourceHealthSource takes this head-to-head with the higher Desk Score, 84/100 (B) against 67/100 (C) for TelePeptide. TelePeptide still holds its ground where its strengths line up with yours.
Choose HealthSource if…
Readers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.
$199/mo (all doses, compounded) sema · $299/mo (all doses, compounded) tirz · All 50 states
Choose TelePeptide if…
Readers who want all-in compounded GLP-1 (sema/tirz, injectable + oral) from $169/mo; LegitScript-certified, 48 states.
$199/mo (starting dose, annual plan, compounded oral) sema · $219/mo (starting dose, annual plan, compounded oral) tirz · Coverage not published
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: HealthSource · TelePeptide.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- HealthSource vs CoreAge Rx
- TelePeptide vs Vaylen
- HealthSource vs Strut Health
- TelePeptide vs Ondra Health
- HealthSource vs Invigor Medical
- TelePeptide vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.